Rongioletti F, Ballestrero A, Bogliolo F, Rebora A
Department of Dermatology, University of Genoa, Italy.
J Cutan Pathol. 1991 Dec;18(6):453-6. doi: 10.1111/j.1600-0560.1991.tb01384.x.
Acral erythema (AE) and eccrine squamous syringometaplasia (ESS) are distinctive clinico-pathological entities described in patients receiving chemotherapy for malignancies, mainly myelogenous leukemia. In no case of chemotherapy-induced AE have histopathologic changes of ESS been described. We report a patient with acute myelogenous leukemia who had typical AE due to cytarabine with histopathologic ESS. The latter findings in a case of AE may be a useful diagnostic clue for distinguishing chemotherapy-induced AE from palmo-plantar erythema of graft-vs-host reaction.
肢端红斑(AE)和小汗腺鳞状化生(ESS)是在接受恶性肿瘤化疗的患者中描述的独特临床病理实体,主要是骨髓性白血病。在化疗诱导的AE病例中,从未描述过ESS的组织病理学变化。我们报告了一名急性骨髓性白血病患者,其因阿糖胞苷出现典型的AE并伴有组织病理学上的ESS。在AE病例中的后一种发现可能是将化疗诱导的AE与移植物抗宿主反应的掌跖红斑区分开来的有用诊断线索。